MDRM Appoints Executive Advisor
19 Marzo 2014 - 8:45PM
Marketwired
MDRM Appoints Executive Advisor
TORONTO, ON--(Marketwired - Mar 19, 2014) - Toronto based Nevada
firm Modern Mobility Aids Inc. (OTC Pink: MDRM) (PINKSHEETS: MDRM)
is pleased to appoint Gilbert Sharpe as Executive Advisor to the
Company. Gilbert, the former long-time Director of the Legal
Branch of the Ontario Ministry of Health and Long-Term Care, brings
invaluable experience from a distinguished 30-year career in legal
practice and advisory roles. His background in public policy,
private sector involvement and college regulatory work is a great
asset to Fasken Martineau's national Health Law Group. Through
Gilbert's involvement with the Ministry of Health since 1975, and
associated work with numerous ministries and agencies of the
Ontario government as well as federal departments, Gilbert has been
involved continuously with important legal issues and policy
matters affecting health care, including the development of
legislation and policies to improve the health care system. As
well, he has been an advocate for educational forums to promote
ongoing and effective exchange of information related to new
initiatives.
Since leaving the Ontario government, Gilbert has continued to
work on numerous health law and policy matters for various clients,
both in the private and public sectors.
Gilbert holds several professorships (Professor, Faculty of
Health Sciences, McMaster University; Professor, Faculty of
Medicine, University of Toronto) as well as other positions
including President of the Canadian Institute of Law and Medicine
and Editor-in-Chief of Health Law in Canada.
Commenting on the Company's newly appointed Legal advisor, Mr.
Declan French, CEO, remarks, "We are excited to have Mr. Gilbert
Sharpe on our advisory team as Gilbert brings three decades of
experience with Health Canada and government regulation. The
Company plans to leverage its expertise in pursuing opportunities
in the growing medical marijuana industry."
In February 2014 MDRM experienced a rapid expansion in the life
sciences and health care industry with a clear focus on the
production of medical marijuana. MDRM's mandate is to acquire
companies within the biopharma and alternative medicine sectors
targeting both innovative research and development as well as
scalable licensed cannabis manufacturing capacity.
The national legalization of medical marijuana by the Canadian
Government has created opportunity for cannabis production and sale
as Canada is currently implementing a new licensing platform which
will create a new rapid growth industry.
CONTACT INFO: Modern Mobility Aids Inc. Public Relations and
shareholder information: investor@mdrmgroup.com
Grafico Azioni Modern Mobility Aids (PK) (USOTC:MDRM)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Modern Mobility Aids (PK) (USOTC:MDRM)
Storico
Da Feb 2024 a Feb 2025
